AHRQ to create rating system for patient-focused info

With the amount of patient-direct information growing, the Agency for Healthcare Research and Quality (AHRQ) is developing a rating system, called the Health Information Rating System. The system was discussed in a Federal Register posting and pays particular attention on patient data provided by EHRs.

The agency's notice stated that health education materials delivered by EHRs “are rarely written in a way that is understandable and actionable for patients with basic or below basic health literacy,” which may be as many as 77 million people. “Persons with limited health literacy face numerous healthcare challenges. They often have a poor understanding of basic medical vocabulary and healthcare concepts.”

Agency officials expect the rating system to address that challenge by giving clinicians a method to determine the quality of the data their systems provide or that such resources are even available.

A draft version of the rating system was applied by researchers at AHRQ to sample educational materials on asthma and colonoscopy and indicated some of the material had “low understandability or low actionability.” The agency plans to next use consumer panels to test the accuracy of the rating system.

Other related health literature activities planned by AHRQ include creating a library of patient health education materials, a review of EHR's patient education capabilities and education of EHR vendors and users.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.